Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Transcranial Direct Current Stimulation (tDCS).

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18-40~2. Within 2-weeks s/p acute grade 1 or 2 ankle inversion sprain~Exclusion Criteria:~1. Self-Reported Pregnancy~2. Being treated for and on medication for a mental health diagnosis~3. Concussion or non-lateral ankle sprain lower extremity injuries within the past 6 months~4. Open wound or dermatologic lesion on the head or region of application~5. Active implantable medical devices such as cochlear implants or cardiac pacemakers, or with metal implants in the head (excluding standard orthodontic braces, fillings, etc.).~6. Epilepsy or history of seizures~7. Participants who are not fluent in English

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Transcranial Direct Current Stimulation plus Physical Therapy (Type: EXPERIMENTAL): Participants in the experimental group will receive the current standard of care in ankle inversion sprain rehabilitation plus a 20-minute application of tDCS during each treatment session via the Halo Sport (Halo Neuroscience, San Francisco, CA) headset. The rehabilitation program will be standardized among all patients and will consist of therapeutic exercises, manual physical therapy, and other modalities. Rehabilitation sessions will be performed 2x weekly and sessions will last approximately 45 to 60 minutes.
- Sham Transcranial Direct Current Stimulation plus Physical Therapy (Type: SHAM_COMPARATOR): Participants in the sham control group will receive the current standard of care in ankle inversion sprain rehabilitation plus a 20-minute sham tDCS treatment, where the patient is wearing the tDCS headset, but stimulation is only applied for 30 seconds of the 20-minute period. The rehabilitation program will be standardized among all patients and will consist of therapeutic exercises, manual physical therapy, and other modalities. Rehabilitation sessions will be performed 2x weekly and sessions will last approximately 45 to 60 minutes.

Based on this trial design, predict the completion outcome and termination type (if applicable).